Gastric carcinoma - PubMed (original) (raw)

Review

. 1998 Oct-Nov;5(7):650-6.

doi: 10.1007/BF02303836.

Affiliations

• PMID: 9831115
• DOI: 10.1007/BF02303836

Review

Gastric carcinoma

M S Karpeh Jr et al. Ann Surg Oncol. 1998 Oct-Nov.

Abstract

Gastric cancer continues to be a major global health problem. In the American College of Surgeons Patient Care study on gastric cancer, 5-year disease-specific survival was 26%, with an overall survival of 14%. Improvements in survival will require both earlier diagnosis and new therapeutic strategies. The ability of surgical oncologists to understand the natural history of the disease, accurately define its extent, and provide the most effective treatment places them in a key position to see that improvements in outcome are brought about expeditiously.

PubMed Disclaimer

Similar articles

• [Gastric surgery].
  Vereczkei A. Vereczkei A. Magy Seb. 2012 Jun;65(3):108-15. doi: 10.1556/MaSeb.65.2012.3.5. Magy Seb. 2012. PMID: 22717965 Review. Hungarian. No abstract available.
• Extended follow-up after extended lymphadenectomy for gastric cancer: was it worth the wait?
  Roggin KK, Hemmerich J, Posner MC. Roggin KK, et al. Lancet Oncol. 2010 May;11(5):404-5. doi: 10.1016/S1470-2045(10)70098-X. Epub 2010 Apr 19. Lancet Oncol. 2010. PMID: 20409753 No abstract available.
• Management of Gastric Adenocarcinoma for General Surgeons.
  Hoshi H. Hoshi H. Surg Clin North Am. 2020 Jun;100(3):523-534. doi: 10.1016/j.suc.2020.02.004. Epub 2020 Mar 18. Surg Clin North Am. 2020. PMID: 32402298 Review.
• Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate.
  Douglass HO Jr, Hundahl SA, Macdonald JS, Khatri VP. Douglass HO Jr, et al. Surg Oncol Clin N Am. 2007 Jan;16(1):133-55. doi: 10.1016/j.soc.2006.10.005. Surg Oncol Clin N Am. 2007. PMID: 17336241 Review.
• Will Rogers and gastric carcinoma.
  Bodner BE. Bodner BE. Arch Surg. 1988 Aug;123(8):1023-4. doi: 10.1001/archsurg.1988.01400320109024. Arch Surg. 1988. PMID: 3395233 No abstract available.

Cited by

• Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study.
  Brisinda G, Chiarello MM, Crocco A, Adams NJ, Fransvea P, Vanella S. Brisinda G, et al. World J Gastroenterol. 2022 Jan 21;28(3):381-398. doi: 10.3748/wjg.v28.i3.381. World J Gastroenterol. 2022. PMID: 35110956 Free PMC article.
• Gastric adenocarcinoma: review and considerations for future directions.
  Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Dicken BJ, et al. Ann Surg. 2005 Jan;241(1):27-39. doi: 10.1097/01.sla.0000149300.28588.23. Ann Surg. 2005. PMID: 15621988 Free PMC article. Review.
• RATIO OF METASTATIC LYMPH NODES VS. RESECTED LYMPH NODES (N-RATIO) HAS PROGNOSTIC IMPLICATIONS IN GASTRIC CANCER.
  Porto BC, Pereira MA, Ramos MFKP, Dias AR, Lopasso FP, D'Albuquerque LAC, Ribeiro Junior U. Porto BC, et al. Arq Bras Cir Dig. 2024 Sep 23;37:e1824. doi: 10.1590/0102-6720202400031e1824. eCollection 2024. Arq Bras Cir Dig. 2024. PMID: 39319897 Free PMC article.
• R0 resection in the treatment of gastric cancer: room for improvement.
  Biondi A, Persiani R, Cananzi F, Zoccali M, Vigorita V, Tufo A, D'Ugo D. Biondi A, et al. World J Gastroenterol. 2010 Jul 21;16(27):3358-70. doi: 10.3748/wjg.v16.i27.3358. World J Gastroenterol. 2010. PMID: 20632437 Free PMC article.
• Prognostic factors in patients with loco-regionally advanced gastric cancer.
  Hultman B, Gunnarsson U, Nygren P, Sundbom M, Glimelius B, Mahteme H. Hultman B, et al. World J Surg Oncol. 2017 Sep 15;15(1):172. doi: 10.1186/s12957-017-1243-z. World J Surg Oncol. 2017. PMID: 28915886 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information